168 related articles for article (PubMed ID: 11527304)
1. Locally recurrent adenoid cystic carcinoma of the left antrum: response to epirubicin, cisplatin and 5-fluorouracil.
Ferguson MJ; Dewar JA
Clin Oncol (R Coll Radiol); 2001; 13(3):236-7. PubMed ID: 11527304
[No Abstract] [Full Text] [Related]
2. Epirubicin, cisplatin and protracted venous infusion 5-Fluorouracil chemotherapy for advanced salivary adenoid cystic carcinoma.
Ross PJ; Teoh EM; A'hern RP; Rhys-Evans PH; Harrington KJ; Nutting CM; Gore ME
Clin Oncol (R Coll Radiol); 2009 May; 21(4):311-4. PubMed ID: 19201585
[TBL] [Abstract][Full Text] [Related]
3. The efficacy and safety of concurrent chemoradiotherapy for maxillary sinus squamous cell carcinoma patients.
Nishimura G; Tsukuda M; Mikami Y; Matsuda H; Horiuchi C; Satake K; Taguchi T; Takahashi M; Kawakami M; Hanamura H; Watanabe M; Utsumi A
Auris Nasus Larynx; 2009 Oct; 36(5):547-54. PubMed ID: 19097833
[TBL] [Abstract][Full Text] [Related]
4. Second-line chemotherapy in recurrent small cell lung cancer. Results from a crossover schedule after primary treatment with cisplatin and etoposide (EP-regimen) or cyclophosphamide, epirubicin, and vincristin (CEV-regimen).
Sundstrøm S; Bremnes RM; Kaasa S; Aasebø U; Aamdal S;
Lung Cancer; 2005 May; 48(2):251-61. PubMed ID: 15829326
[TBL] [Abstract][Full Text] [Related]
5. A combination immunochemotherapy of 5-fluorouracil, cisplatin, leucovorin, and OK-432 for advanced and recurrent gastric carcinoma.
Yoshikawa T; Tsuburaya A; Kobayashi O; Sairenji M; Motohashi H; Noguchi Y
Hepatogastroenterology; 2003; 50(54):2259-63. PubMed ID: 14696512
[TBL] [Abstract][Full Text] [Related]
6. A phase II evaluation of a 3-hour infusion of paclitaxel, cisplatin, and 5-fluorouracil in patients with advanced or recurrent squamous cell carcinoma of the head and neck: Southwest Oncology Group study 0007.
Worden FP; Moon J; Samlowski W; Clark JI; Dakhil SR; Williamson S; Urba SG; Ensley J; Hussain MH;
Cancer; 2006 Jul; 107(2):319-27. PubMed ID: 16779801
[TBL] [Abstract][Full Text] [Related]
7. Cisplatin, epirubicin and 5-fluorouracil combination chemotherapy for recurrent carcinoma of the salivary gland.
Airoldi M; Pedani F; Brando V; Gabriele P; Giordano C
Tumori; 1989 Jun; 75(3):252-6. PubMed ID: 2475951
[TBL] [Abstract][Full Text] [Related]
8. Chemoradiotherapy for locally recurrent nasopharyngeal carcinoma: treatment outcome and prognostic factors.
Nakamura T; Kodaira T; Tachibana H; Tomita N; Tomoda T; Nakahara R; Inokuchi H; Mizoguchi N; Takada A; Fuwa N
Jpn J Clin Oncol; 2008 Dec; 38(12):803-9. PubMed ID: 18840881
[TBL] [Abstract][Full Text] [Related]
9. Systemic chemotherapy with cisplatin plus 5-FU (PF) for recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): efficacy and safety of a lower dose of PF (80/800) at a single institution in Japan.
Kiyota N; Tahara M; Kadowaki S; Fuse N; Doi T; Minami H; Ohtsu A
Jpn J Clin Oncol; 2009 Apr; 39(4):225-30. PubMed ID: 19211574
[TBL] [Abstract][Full Text] [Related]
10. A new aspect of tri-modal therapy with superselective intra-arterial chemotherapy in maxillary sinus carcinoma.
Fujishiro Y; Nakao K; Watanabe K; Ebihara Y; Nakamura N; Mori H; Hayashi N; Asakage T
Acta Otolaryngol Suppl; 2007 Dec; (559):151-6. PubMed ID: 18340587
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous radiochemotherapy in cervical cancer: recommendations for chemotherapy.
Dunst J; Haensgen G
Strahlenther Onkol; 2001 Dec; 177(12):635-40. PubMed ID: 11789401
[TBL] [Abstract][Full Text] [Related]
12. Intraarterial cisplatin with intravenous paclitaxel and ifosfamide as an organ-preservation approach in patients with paranasal sinus carcinoma.
Papadimitrakopoulou VA; Ginsberg LE; Garden AS; Kies MS; Glisson BS; Diaz EM; Clayman G; Morrison WH; Liu DD; Blumenschein G; Lippman SM; Schommer D; Gillenwater A; Goepfert H; Hong WK
Cancer; 2003 Nov; 98(10):2214-23. PubMed ID: 14601092
[TBL] [Abstract][Full Text] [Related]
13. Cylindroma of the maxillary antrum. A case presentation and review of the literature.
Greenbaum EI; Gunn W; Rappaport I; O'Loughlin BJ
Radiol Clin Biol; 1970; 39(5):419-26. PubMed ID: 4319129
[No Abstract] [Full Text] [Related]
14. Proton beam radiation therapy for skull base adenoid cystic carcinoma.
Pommier P; Liebsch NJ; Deschler DG; Lin DT; McIntyre JF; Barker FG; Adams JA; Lopes VV; Varvares M; Loeffler JS; Chan AW
Arch Otolaryngol Head Neck Surg; 2006 Nov; 132(11):1242-9. PubMed ID: 17116822
[TBL] [Abstract][Full Text] [Related]
15. [Therapeutic options in sinunasal adenoid cystic carcinomas--a case report and review].
Mozet C; Stumpp P; Mekonnen B; Dietz A
Laryngorhinootologie; 2009 Oct; 88(10):631-8. PubMed ID: 19813159
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy of the combination of 5 fluorouracil, adriamycin and cisplatin (FAP protocol) in the treatment of metastatic cylindroma. Apropos of a case with review of the literature].
Farhat F; Kattan J; Culine S; Bekradda M; Droz JP
Bull Cancer; 1994 Jan; 81(1):47-50. PubMed ID: 7949584
[TBL] [Abstract][Full Text] [Related]
17. Unresectable adenoid cystic carcinoma of the trachea treated with chemoradiotherapy.
Sasiaja M; Funa N; Kamata M; Furutani K; Matsumoto A; Kodaira T
Clin Oncol (R Coll Radiol); 2000; 12(4):272. PubMed ID: 11005697
[No Abstract] [Full Text] [Related]
18. Multifractionated paclitaxel and cisplatin combined with 5-fluorouracil and leucovorin in patients with metastatic or recurrent esophageal squamous cell carcinoma.
Lin CC; Yeh KH; Yang CH; Hsu C; Tsai YC; Hsu WL; Cheng AL; Hsu CH
Anticancer Drugs; 2007 Jul; 18(6):703-8. PubMed ID: 17762400
[TBL] [Abstract][Full Text] [Related]
19. First-line chemotherapy with fluorouracil-epirubicin-navelbine (FEN) combination in advanced breast cancer.
Ardavanis A; Tryfonopoulos D; Orphanos G; Ioannidis G; Karamouzis M; Rigatos G
Anticancer Res; 2005; 25(6C):4493-8. PubMed ID: 16334132
[TBL] [Abstract][Full Text] [Related]
20. Concurrent chemoradiotherapy in locoregionally recurrent nasopharyngeal carcinoma.
Poon D; Yap SP; Wong ZW; Cheung YB; Leong SS; Wee J; Tan T; Fong KW; Chua ET; Tan EH
Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1312-8. PubMed ID: 15275714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
